Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Rheumatology
•
Pulmonology
What is the dose and duration of steroids for someone with pulmonary manifestations of VEXAS?
Related Questions
How do you approach management of adult patients with CVID and sarcoid-like syndrome?
Do you consider pulmonary hypertension related to sarcoidosis to be an indication to start steroids?
Do you consider immunosuppressive agents in progressive interstitial pneumonias or pneumonitis without a clear driving etiology?
How do you approach management of a patient with Sjogren's disease and lung mass biopsy revealing amyloidosis?
How do you workup patients with neuropathy suspected to be secondary to sarcoid?
What is your approach to monitoring patients with cardiac sarcoid while tapering immunosuppression?
What else do you consider in the differential diagnosis for pulmonary-renal syndromes if there is low clinical and serologic evidence of AAV, Goodpasture's or other rheumatologic disease (SLE, RA, APS, Scleroderma)?
In light of the RECITAL study, would rituximab be a reasonable choice in a patient with PL-12 antibodies, rapidly progressive pulmonary disease with organizing pneumonia on biopsy?
How would you approach medication de-escalation in a patient with a history of rapidly progressive CTD-ILD who responded to and is currently on mycophenolate 3 grams daily and IVIG 2mg/kg monthly infusions and has been stable for two years?
What is your approach to a patient who has a cardiac PET scan suggestive of sarcoid but no other supporting evidence of a diagnosis of sarcoid?
